Artificial Intelligence meets Health
- from desk to bench to bedside -
Date and location:
11 November, 09:30 am
German Cancer Research Center, Heidelberg
Deadlines:
Registration - 6 November
Abstracts and Posters - early submission July 31
- late submission September 15
Programme
09:30 - 10:00
Registration & Get-together
10:00 - 10:30
Welcome
Gitte Neubauer - Cellzome, a GSK Company and BioRN Executive Board
Michael Boutros - German Cancer Research Center (DKFZ) and BioRN Executive Board
Theresia Bauer - Minister of Science, Research and the Arts, Member of the State Government of Baden-Württemberg
10:30 - 11:00
Keynote - The resolution revolution and the consequences for Heidelberg
Stefan Hell - Max Planck Institute for Medical Research, Heidelberg and Max Planck Institute for Biophysical Chemistry, Göttingen
11:00 - 11:20
Computational single-cell genomics - advances and translational opportunities
Oliver Stegle - German Cancer Research Center (DKFZ) and European Molecular Biology Laboratory (EMBL)
11:20 - 11:40
Machine Learning in Computer-aided Drug Design
Rebecca Wade - Heidelberg Institute for Theoretical Studies (HITS) and Heidelberg University
11:40 - 12:30
Research Short-Talks: project pitching by PhD Students and Postdoctoral Fellows
12:30 - 14:00
Lunch & Networking & Industry Poster Exhibition
14:00 - 14:40
HAEP - A Novel Format to Foster Academia-Industry Partnerships
Friedemann Loos, BioRN
HAEP Success Stories:
-
Closing the gap between “episteme” and “techne”: challenges for successful biotechnology transfer Patrick Most - University Hospital Heidelberg, Jefferson University and AaviGen GmbH
-
Artificial Intelligence: Deep Learning in Medicine, Myth or Reality? Sergey Biniaminov - HS Analysis
-
Organs-On-A-Chip And Artificial Intelligence Platforms In Personalized Medication Development - Ute Schepers - Karlsruhe Institute of Technology (KIT) and VasQlab
14:40 - 15:00
opnMe.com, a digital platform for sharing chemical tools
Adrian Carter - Boehringer Ingelheim
15:00 - 15:20
Value and Challenges of Data-Explosion in Pharma R&D
Lars Greiffenberg - AbbVie
15:20 - 15:40
Artificial Intelligence - Benchmarking research in the Rhein-Neckar Region and implications for Life Science Players
Maria de Kleijn - Elsevier
15:40 - 16:00
AI in Drug Discovery at Merck: benefits and perspectives
Friedrich Rippmann - Merck
16:00 - 16:20
Robust Tumor Heterogeneity Characterization from Single-cell Sequencing with Graph-based Artificial Intelligence
Brandon Malone - NEC Laboratories Europe GmbH
16:20 - 16:50
Keynote - Artificial intelligence: What exactly is it, and how can it support drug discovery?
Lindsay Edwards - GlaxoSmithKline
16:50 - 17:00
Research Short Talk AWARD & Closing Remarks
Michael Boutros - German Cancer Research Center (DKFZ) and BioRN Executive Board
from 17:00
Get-together
Hosted at:
Key Public Partner:
